Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA2A | P29274 | 6/20 | 0.42 |
| ▸ | ADORA3 | P0DMS8 | 3/20 | 0.42 |
| ▸ | ADORA1 | P30542 | 2/20 | 0.42 |
| ▸ | PDE2A | O00408 | 1/20 | 0.42 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.42 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.42 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.42 |
| ▸ | RNASEL | Q05823 | 3/20 | 0.40 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.40 |
| ▸ | DNMT1 | P26358 | 1/20 | 0.40 |
| ▸ | DNMT3B | Q9UBC3 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | NT5E | P21589 | 1/20 | 0.40 |
| ▸ | AHCY | P23526 | 1/20 | 0.39 |
| ▸ | ADORA2B | P29275 | 3/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21614180 | 0.90 | NT5E (0.52) | ADORA2AADORA3ADORA1PDE2AADRA1A | |
| SCHEMBL17927851 | 0.85 | AHCY (0.55) | ADORA2AADORA3ADORA1HIF1AAHCY | |
| SCHEMBL16214136 | 0.85 | AHCY (0.55) | ADORA2AADORA3ADORA1HIF1AAHCY | |
| SCHEMBL24831397 | 0.85 | AHCY (0.55) | ADORA2AADORA3ADORA1HIF1AAHCY | |
| SCHEMBL16214098 | 0.83 | SLC29A1 (0.38) | ADORA2AADORA3ADORA1PDE2AADRA1A | |
| SCHEMBL16214124 | 0.82 | SLC29A1 (0.38) | ADORA2AADORA3ADORA1PDE2AADRA1A | |
| SCHEMBL26311386 | 0.82 | AHCY (0.45) | ADORA2AADORA3ADORA1PDE2AADRA1A | |
| SCHEMBL16214074 | 0.82 | AHCY (0.41) | ADORA2AADORA3ADORA1HIF1AAHCY | |
| SCHEMBL16858614 | 0.81 | ADORA3 (0.48) | ADORA3PDE3ANT5E | |
| SCHEMBL16214090 | 0.81 | ADORA3 (0.48) | ADORA3PDE3ANT5E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230277576-A1 | A METHOD FOR PREVENTING OR TREATING A CORNAVIRUS INFECTIOUS DISEASE | HENAN GENUINE BIOTECH CO., LTD. (CN) | 2023-09-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230277576-A1 | A METHOD FOR PREVENTING OR TREATING A CORNAVIRUS INFECTIOUS DISEASE | ACE, ACE2, SARS1 | ADORA2A 4232/4885ADORA3 3008/4885ADORA1 2493/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.